» Articles » PMID: 15213060

Downward Resetting of the Osmotic Threshold for Thirst in Patients with SIADH

Overview
Date 2004 Jun 24
PMID 15213060
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

The syndrome of inappropriate antidiuretic hormone (SIADH) is characterized by euvolemic hyponatremia. Patients with SIADH continue to drink normal amounts of fluid, despite plasma osmolalities well below the physiological osmotic threshold for onset of thirst. The regulation of thirst has not been previously studied in SIADH. We studied the characteristics of osmotically stimulated thirst and arginine vasopressin (AVP) secretion in eight subjects with SIADH and eight healthy controls and the nonosmotic suppression of thirst and AVP during drinking in the same subjects. Subjects underwent a 2-h infusion of hypertonic (855 mmol/l) NaCl solution, followed by 30 min of free access to water. Thirst rose significantly in both SIADH (1.5 +/- 0.6 to 8.0 +/- 1.2 cm, P < 0.0001) and controls (1.8 +/- 0.8 to 8.4 +/- 1.5 cm, P < 0.0001), but the osmotic threshold for thirst was lower in SIADH (264 +/- 5.5 vs. 285.9 +/- 2.8 mosmol/kgH(2)O, P < 0.0001). SIADH subjects drank volumes of water similar to controls after cessation of the infusion (948.8 +/- 207.6 vs. 1,091 +/- 184 ml, P = 0.23). The act of drinking suppressed thirst in both SIADH and controls but did not suppress plasma AVP concentrations in SIADH compared with controls (P = 0.007). We conclude that there is downward resetting of the osmotic threshold for thirst in SIADH but that thirst responds to osmotic stimulation and is suppressed by drinking around the lowered set point. In addition, we demonstrated that drinking does not completely suppress plasma AVP in SIADH.

Citing Articles

A Conspectus of Euvolemic Hyponatremia, Its Various Etiologies, and Treatment Modalities: A Comprehensive Review of the Literature.

Ghosal A, Qadeer H, Nekkanti S, Pradhan P, Okoye C, Waqar D Cureus. 2023; 15(8):e43390.

PMID: 37700952 PMC: 10495223. DOI: 10.7759/cureus.43390.


Tolvaptan and urea in paediatric hyponatraemia.

Veligratli F, Alexandrou D, Shah S, Amin R, Dattani M, Gan H Pediatr Nephrol. 2023; 39(1):177-183.

PMID: 37466863 DOI: 10.1007/s00467-023-06091-w.


Hyponatraemia and the syndrome of inappropriate antidiuresis (SIAD) in cancer.

Donald D, Sherlock M, Thompson C Endocr Oncol. 2023; 2(1):R78-R89.

PMID: 37435459 PMC: 10259335. DOI: 10.1530/EO-22-0056.


Syndrome of Inappropriate Antidiuresis: From Pathophysiology to Management.

Warren A, Grossmann M, Christ-Crain M, Russell N Endocr Rev. 2023; 44(5):819-861.

PMID: 36974717 PMC: 10502587. DOI: 10.1210/endrev/bnad010.


The management of acute and chronic hyponatraemia.

Lawless S, Thompson C, Garrahy A Ther Adv Endocrinol Metab. 2022; 13:20420188221097343.

PMID: 35586730 PMC: 9109487. DOI: 10.1177/20420188221097343.